Vol 3: Immunological targeting of cytomegalovirus for glioblastoma therapy.Report as inadecuate



 Vol 3: Immunological targeting of cytomegalovirus for glioblastoma therapy.


Vol 3: Immunological targeting of cytomegalovirus for glioblastoma therapy. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 3: Immunological targeting of cytomegalovirus for glioblastoma therapy.
This article is from Oncoimmunology, volume 3.AbstractHuman cytomegalovirus CMV is purportedly present in glioblastoma GBM while absent from the normal brain, making CMV antigens potentially ideal immunological anti-GBM targets. We recently demonstrated that patient-derived CMV pp65-specific T cells are capable of recognizing and killing autologous GBM tumor cells. This data supports CMV antigen-directed immunotherapies against GBM.



Author: Nair, Smita K; Sampson, John H; Mitchell, Duane A

Source: https://archive.org/







Related documents